# Medical Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/medical-oncology/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1357-0560 |
| ISSNs | 1357-0560,1559-131X |
| OpenAlex ID | https://openalex.org/S204953464 |
| Publisher | Springer Science+Business Media |

## Journal papers

Showing 12 of 22.

- [Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation](https://scholariq.org/papers/long-non-coding-rna-malat-1-overexpression-predicts-tumor-recurrence-of/)
- [Current status of enhanced recovery after surgery (ERAS) protocol in gastrointestinal surgery](https://scholariq.org/papers/current-status-of-enhanced-recovery-after-surgery-eras-protocol-in/)
- [Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer](https://scholariq.org/papers/initial-neutrophil-lymphocyte-ratio-is-superior-to-platelet-lymphocyte-ratio-as/)
- [O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation](https://scholariq.org/papers/o-glcnacylation-plays-a-role-in-tumor-recurrence-of-hepatocellular-carcinoma/)
- [Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma](https://scholariq.org/papers/co-expression-of-pd-1-and-pd-l1-predicts-poor-outcome-in-nasopharyngeal/)
- [A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results](https://scholariq.org/papers/a-double-blind-placebo-controlled-randomized-phase-iii-trial-of-chemotherapy/)
- [FLT3–ITD and its current role in acute myeloid leukaemia](https://scholariq.org/papers/flt3-itd-and-its-current-role-in-acute-myeloid-leukaemia/)
- [Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation](https://scholariq.org/papers/anti-angiogenic-genistein-inhibits-vegf-induced-endothelial-cell-activation-by/)
- [Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis](https://scholariq.org/papers/overexpression-of-sglt1-and-egfr-in-colorectal-cancer-showing-a-correlation-with/)
- [A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy](https://scholariq.org/papers/a-phase-ii-study-of-biweekly-paclitaxel-and-cisplatin-chemotherapy-for-recurrent/)
- [Correlation of EGFR mutation and predominant histologic subtype according to the new lung adenocarcinoma classification in Chinese patients](https://scholariq.org/papers/correlation-of-egfr-mutation-and-predominant-histologic-subtype-according-to-the/)
- [Integrating complementary medicine in supportive cancer care models across four continents](https://scholariq.org/papers/integrating-complementary-medicine-in-supportive-cancer-care-models-across-four/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.